ClinicalTrials.Veeva

Menu

Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Enrolling

Conditions

Alzheimer's Disease Diagnosis

Study type

Observational

Funder types

Other

Identifiers

NCT05020626
2021.243

Details and patient eligibility

About

The most significant impact of this project is to propose for the first time a novel generative adversarial network (GAN), as one kind of deep learning architecture, to automatically generate synthetic PET images reflecting tau deposition, from brain DTI images. If successful, this framework will become the most state-of-the-art approach to simulate the stereotypical pattern of intracerebral tau accumulation and distribution in vivo.

Synthetic tau-PET images via DTI, possessing overwhelming superiority in radiation-free, non-invasiveness and cost-effectiveness, will potentially serve as one of alternative modalities of PET in detecting tau-load and probably outperform PET on accessibility, generalizability, and availability in future, making it much more attractive in clinical application. A big conceptual shift may occur preferring a fire-new tau-PET simulated via DTI.

The DTI data-driven deep learning framework to be created in this project will constitute an accurate, robust, clinically applicable and explainable tool to efficiently categorize the subjects into tau-burden positive and tau-burden negative cases, which will undoubtedly contribute to both clinical and research activities.

Enrollment

250 estimated patients

Sex

All

Ages

55+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • With the age of 55 years and above
  • With brain MRI taken within ±6 months from the date of clinically confirmed diagnosis of AD, MCI or normal cognition.

Exclusion criteria

  • AD with mixed dementia
  • Non-AD dementia
  • History of severe traumatic brain injury, severe depression, stroke, brain tumors, and incident major systemic illness

Trial design

250 participants in 3 patient groups

Controls
Mild cognitive impairment
AD dementia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems